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ABSTRACT
Objectives: Despite their increasing importance, the ad-
vanced elderly are often neglected in service utilization and
costing studies. The purpose of this study was to analyze from
societal perspective service utilization and direct health-care
costs and its predictors in the advanced elderly population.
Methods: A bottom-up costing study was conducted using
a cross-sectional primary care sample aged 75+ (n = 452)
in Germany. The main instruments were a questionnaire of
service utilization and costs administered by an interviewer
and the chronic disease score (CDS). Predictors were derived
by means of multivariate regression models.
Results: Respondents caused mean direct costs of €3730
(95% CI 3203–4257) in prices of 2004/2005. This included
inpatient care 34%, pharmaceuticals 29%, outpatient physi-
cian services 15%, nursing care 10%, medical supply and
dentures 6%, outpatient nonphysician providers 5%, assisted
living 1%, and transportation 2%. A shift from lower to
middle education and a one-point increase in CDS were
associated with an increase of €1678 (95% CI 250–3369)
and €482 (95% CI 316–654), respectively. Total mean direct
costs did not differ signiﬁcantly between sexes. Ischemic
heart disease and diabetes mellitus were associated with
excess costs of €711 and €290, both being not signiﬁcant.
Altogether 55% of the respondents accounted for 90% of
total direct costs.
Conclusions: Advanced elderly used a wide range of health
services. Our study still underestimates the true costs to
society. Further research should focus on economic evalua-
tion of new health-care programs for this increasingly impor-
tant age group.
Keywords: advanced elderly, direct health-care costs, excess
costs, primary care sample, service utilization.
Introduction
Because of changes in fertility and mortality rates
during the 20th century, demographic structure in
Germany and most other European countries will
change substantially within the coming decades. At
present, 19% of the German population is aged 65+.
By 2050 about 32% of the population will be 65+, of
whom 40% will be 80+, underlining the importance of
the advanced elderly among senior citizens [1]. There
has been a long and still ongoing debate about the
determinants of future health care and long-term care
expenditures [2–9]. Although the extent is being dis-
puted, demographic change is expected to be an impor-
tant driver for all health-care services and health-care
costs regardless of the coverage by social security
systems. Because of age-speciﬁc morbidity patterns
and patient preferences, population aging will signiﬁ-
cantly change the quality, quantity, and structure of
health-care services and goods demanded. In order to
enable future health-care planning, reliable informa-
tion on service utilization patterns and cost compo-
nents from a societal perspective and their predictors is
becoming increasingly important.
So far, the advanced elderly have been mostly
underrepresented in service utilization and costing
studies of the elderly, or they have not been analyzed
speciﬁcally [10–13]. Studies dealing exclusively with
the advanced elderly have focused only on a narrow
range of service utilization, costs, or indications
[14–17]. Internationally, the present study is to our
knowledge the ﬁrst analysing in detail service utiliza-
tion and direct health-care costs from a societal
perspective in a primary care sample aged 75+. Fur-
thermore, this study analyzes excess service utilization
and costs associated with ischemic heart disease
including coronary heart disease/myocardial infarct
(I20–I25, ICD-10-GM 2006) and diabetes mellitus
(E10–E14, ICD-10-GM 2006) [18] highly prevalent in
this age group.
Materials and Methods
Sample
This cross-sectional analysis is part of a prospective
cohort study on early detection of mild cognitive
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impairment and dementia founded by the German
Research Network on Dementia (KND). A total of
1133 randomly selected individuals from 20 ofﬁces of
general practitioners (GPs) in the city of Leipzig
(Saxony), East Germany, meeting the inclusion criteria
received a postal invitation from their GP to partici-
pate in the study. Inclusion criteria consisted of being
aged 75 years or older and having had at least one visit
to the GP within the last 12 months. Exclusion criteria
were dementia, GP consultations only through home
visits, residence in a nursing home, severe illness
which, according to the GP, would prove fatal within
3 months, insufﬁcient ability to speak German, deaf-
ness or blindness, lacking ability to consent, and being
only an occasional patient of the participating GP.
A total of 531 individuals (46.9%) consented to
participate in the KND, of which 452 patients (85.1%)
completed the health economic interview (HEI)
between May 2004 and December 2005. Fifty-one
patients (9.6%) refused to participate in the HEI, 17
(3.2%) had died before the interview, and 11 patients
(2.1%) were additionally excluded because of marked
cognitive impairment detected by neuropsychological
assessment within the KND study. Participants in the
HEI differed signiﬁcantly from the remainder (n = 681)
of the sample in terms of age (T = 4.533, P = 0.000)
and sex (c2 = 5.124, P = 0.024). Nonparticipants were
somewhat older than participants (mean 80.7 vs.
79.6 years), and women were more likely to refuse
participation (70.1% vs. 63.7%).
Sociodemographic and Health-Related Variables
Besides the battery of neuropsychological assessments
used in the KND, sociodemographic data (age, sex,
family status, living situation, and education) were
collected. Education was measured using the revised
version of the Comparative Analysis of Social Mobility
in Industrial Nations classiﬁcation system (CASMIN)
[19]. Furthermore, the chronic disease score (CDS)
[20], adapted for Germany, was calculated. The CDS
measures chronic medical illness, thus classifying each
patient according to the number of drug agents for
treating chronic medical conditions or progressive
diseases (e.g., heart disease, hypertension, diabetes mel-
litus, cancer). Psychotropic medications and medica-
tions used primarily for symptom management (e.g.,
analgesics) are not included in the index. The indivi-
dual CDS is calculated from the sum of scores of medi-
cation in the different medication classes. In addition,
a questionnaire for existing diseases completed by the
GP was used.
Resource Utilization
Medical and nonmedical resource utilization was
assessed face-to-face with a structured interview con-
ducted at the patient’s home by skilled staff of the
Department of Psychiatry of the University of Leipzig.
The questionnaire of service utilization and costs was
based on cost diaries used in earlier studies [21–24]
which were adapted to the purposes of the present
study. To minimize recall biases resource utilization
was assessed retrospectively over different time spans:
outpatient physician services, use of outpatient non-
physician providers, medical supply and dentures,
pharmaceuticals and transportation to and from
medical treatments during the past 3 months, inpatient
care and assisted living during the past 6 months,
and use of nursing care during the past 12 months.
Depending on the service, measures of utilization, that
is, type, frequencies of use or mean duration were
recorded (Table 1). To further account for recall biases
schedules of possible services were presented. For
example, we addressed every outpatient service speciﬁ-
cally in the questionnaire. The instrument is available
from the authors. Excess service utilization associated
with a disease (ischemic heart disease or diabetes mel-
litus) was calculated as the difference between the
Table 1 Resources, units, and monetary valuation used for calculation of costs
Sector Services/goods Units Monetary valuation (2004/2005)
Inpatient care General hospitals, specialized hospitals for
psychiatric and neurological care, hospitals
for rehabilitations
Days Type-speciﬁc mean rates per diem in
Saxony and Eastern Germany
Pharmaceuticals Product Quantity Red List
Outpatient physician service GP, specialists (e.g., cardiologist, internist,
ophthalmologist) and outpatient clinic
Minutes of
contacts
Type-speciﬁc mean costs per minute*
Nursing care Beneﬁts and services from compulsory
long-term care insurance and privately paid
expenses
Days Rates of compulsory long-term care
insurance, market prices
Assisted living Service Days Market prices
Medical supply and dentures Product Quantity Market prices
Outpatient nonphysician provider e.g., physiotherapy, massage, lymph drainage,
ergotherapy
Contacts List of fees paid by AOK Saxony
Transportation Transportation by car, public transport, taxi, or
ambulance to medical visits or treatment
km, quantity €0.30/km for car driving, market prices
*Surgeries performed in an outpatient setting were valued based on Einheitlicher Bewertungsmaßstab.
AOK,Allgemeine Ortskrankenkasse; GP, general practitioner.
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group of respondents who had the disease and respon-
dents who had not, thereby taking also into account
services of the corresponding comorbidities and their
interaction. For both groups the proportions of users
of the various services during the distinct time spans
were calculated and subtracted.
Unit Costs
To determine direct health-care costs, unit costs from a
societal perspective were calculated for all services
used and for all goods privately purchased or pre-
scribed. Costs were determined for the different time
spans of resource utilization and then extrapolated to
annual costs by multiplying them by 4 (3 months) and
2 (6 months). This reﬂects the underlying assumption
that the same pattern of resource utilization would
also be found over a 12-month period. Costs were
calculated in EUR at 2004/2005 price levels. If unit
cost data were only available for years before 2004,
costs were inﬂated to the base year 2004 using the
consumer price index [25]. Market prices were used as
reported in the questionnaire and therefore reﬂect
prices in the years 2004 and 2005. Detailed informa-
tion regarding monetary valuation is shown in Table 1.
Costs for inpatient care in base-case analysis were
calculated using hospital type-speciﬁc mean rates per
diem for the region [26–28]. For sensitivity analysis,
costs of general hospital care were calculated using
case rates based on Diagnosis-Related Groups (DRG)
[29,30]. Pharmaceutical costs were calculated using
prices from the German catalog of drugs (Red list
[Rote Liste]) [31]. Outpatient physician costs were also
calculated in two different ways. For base-case analysis
mean costs per minute, differentiated by type of
physician, were used, based on data provided by the
Central Institute for Outpatient Physicians and the
Federal Dentist Association [32,33]. In sensitivity
analysis the reimbursement catalog of the compulsory
sickness funds was applied, which values medical ser-
vices according to a “relative value scale” (Einheit-
licher Bewertungsmaßstab) [34,35]. Costs of medical
services are then determined by a monetary conversion
factor. For this study, the monetary conversion factor
for Saxony in 2004 was €0.045 and was used for all
calculations of outpatient physician costs. Costs of
nursing care and assisted living were calculated using
the reimbursement rates of compulsory long-term care
insurance, and privately paid expenses according to
patients’ speciﬁcations [36]. Costs for medical supply
and dentures were calculated using market prices.
Costs for outpatient nonphysician providers were cal-
culated according to an established billing catalog
of the largest compulsory sickness fund (Allgemeine
Ortskrankenkasse [AOK] Saxony) of the region, where
most of the participants were insured. Costs of car
travel were calculated according to the number of kilo-
metres travelled multiplied by a ﬂat rate of €0.30/km
(according to the tax-deductible rate allowed for trips
to and from work) [37]. Costs for travel on public
transport or in taxis were calculated according to
patient speciﬁcations. Excess costs associated with
ischemic heart disease or diabetes mellitus were calcu-
lated analogously to excess service utilization. For
both groups annual mean costs were calculated and
subtracted. If not otherwise stated costs are reported as
annual costs.
Statistical Analysis
Statistical analysis was performed using SPSS 12.0.1
(SPSS Inc., Chicago, IL) and STATA Release 9 (Stata
Corp., College Station, TX). Missing in service utiliza-
tion and cost data was imputed with unconditional
means. Means of the observed data for the correspond-
ing variables were calculated and then imputed. Fre-
quencies, percentages, measures of central tendency,
and variability were calculated. Differences in propor-
tions were analyzed using chi-square tests and, where
appropriate, Fisher’s exact test. To test for differences
in means of continuous data with large sample sizes,
Student’s t-test was used. Because service utilization
and cost data tend to be highly skewed, alternatively
the nonparametric Mann–Whitney U-test was applied
and reported in the tables. The level of signiﬁcance
was set at a = 0.05. Where appropriate, conﬁdence
intervals were calculated. All results displayed are
unadjusted.
To understand the effect of socio-demographic (age,
sex, family status, education level) and health-related
variables on total costs and to predict future costs in
EUR, one-part models with untransformed costs have
been recommended [38,39]. Therefore, multiple linear
regression models with nonparametric bootstrapped
standard errors (3000 replications) and bias-corrected
conﬁdence intervals were used [40–42].
Results
Study Population
Main characteristics of the study population are
shown in Table 2. Signiﬁcant differences between sexes
were found in family status, living situation, and edu-
cation. Most men were married (72.0%) and therefore
living with spouse or partner (73.8%); most women
were widowed (56.3%) and subsequently living alone
(65.6%). More men (51.2%) had middle or high edu-
cation than women (29.1%). The age range at re-
tirement was 40 to 80 years with peaks at 60 and
65 years. All respondents were insured with compul-
sory sickness funds (70% AOK, 15% substitution
funds [Ersatzkasse], and 15% other). With one excep-
tion, all respondents had German as their mother
tongue.
Eighty-one percent of the respondents answered the
interview without missing values. The average number
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of missing values per interview was 0.3. Missing values
especially occurred with the following variables: prices
of medical supply and dentures, form of pharmaceuti-
cals (e.g., tablets), and whether the pharmaceutical
was taken the whole period or not. According to the
interviewers, the respective questions were the most
difﬁcult to answer by the respondents.
Service Utilization and Costs
Total service utilization and costs. A total of 99.3% of
the advanced elderly utilized at least one health-care
service/good in the time spans considered. Annual
mean total direct costs per respondent amounted to
€3730 (95% CI 3203–4257). Costs ranged from €0 to
€65,302, with no signiﬁcant difference between sexes
(Table 3).
Inpatient care. Inpatient care was utilized by 17.3%
of the respondents during the preceding 6 months with
no signiﬁcant difference between women and men.
13.9% of the respondents had been admitted to
general hospitals with an average number of admis-
sions of 1.3 and an average length of stay of 10.5 days.
Table 2 Sample characteristics
Characteristics
All
n = 452
Female
n = 288
Male
n = 164 P-value*
Age (year) n.s.†
Mean (SD) 80.91 (3.69) 81.16 (3.75) 80.46 (3.54)
Median (range) 80.00 (75–94) 81.00 (75–93) 80.00 (75–94)
Family status: n (%) <0.001‡
Single 38 (8.4) 34 (11.8) 4 (2.4)
Married 192 (42.5) 74 (25.7) 118 (72.0)
Divorced 22 (4.9) 18 (6.3) 4 (2.4)
Widowed 200 (44.2) 162 (56.3) 38 (23.2)
Living situation: n (%) <0.001§
Alone 228 (50.4) 189 (65.6) 39 (23.8)
With spouse/partner 196 (43.4) 75 (26.0) 121 (73.8)
With relatives 11 (2.4) 11 (3.8) —
Other 17 (3.8) 13 (4.5) 4 (2.4)
Education:¶ n (%) <0.001‡
Low 284 (62.8) 204 (70.8) 80 (48.8)
Middle 85 (18.8) 62 (21.5) 23 (14.0)
High 83 (18.4) 22 (7.6) 61 (37.2)
CDS n.s.†
Mean (SD) 4.82 (2.67) 4.64 (2.59) 5.13 (2.78)
Median (range) 5.00 (0–13) 5.00 (0–13) 5.00 (0–13)
*Test for signiﬁcance between sexes.
†t-test.
‡c2-test.
§Fisher’s exact test.
¶Revised version of the CASMIN classiﬁcation.
CDS, chronic disease score; n.s., not signiﬁcant.
Table 3 Service utilization and costs
Sector
Number (%) of respondents using service* Mean annual costs in EUR per respondent (SD)
All
n = 452
Female
n = 288
Male
n = 164 P-value†
All, n = 452 Female
n = 288
Male
n = 164 P-value‡Absolute %
Inpatient care 78 (17.3) 45 (15.6) 33 (20.1) n.s.§ 1260 (3645) 34 1233 (3751) 1309 (3462) n.s.
Pharmaceuticals 443 (98.0) 287 (99.7) 156 (95.1) 0.002¶ 1075 (1969) 29 1072 (1924) 1081 (2051) n.s.
Outpatient physician service 443 (98.0) 285 (99.0) 158 (96.3) n.s.¶ 546 (1937) 15 443 (433) 727 (3163) n.s.
Nursing care 103 (22.8) 77 (26.7) 26 (15.9) 0.008§ 361 (1380) 10 461 (1647) 186 (668) 0.013
Assisted living 20 (4.4) 17 (5.9) 3 (1.8) 0.043§ 34 (177) 1 48 (211) 10 (86) 0.006
Medical supply and dentures 71 (15.7) 54 (18.8) 17 (10.4) 0.019§ 217 (934) 6 221 (872) 208 (1037) n.s.
Outpatient nonphysician
provider
131 (29.0) 94 (32.6) 37 (22.6) 0.023§ 170 (380) 5 206 (433) 106 (253) 0.002
Transportation 243 (53.8) 155 (53.8) 88 (53.7) n.s.§ 67 (196) 2 60 (160) 77 (246) n.s.
Any service/good 449 (99.3) 288 (100) 161 (98.2) 0.047¶ 3730 (5719) 100 3744 (5223) 3704 (6517) n.s.
*During the preceding 3 months except for inpatient care, assisted living (6 months), and nursing care (12 months).
†Test for signiﬁcance between sexes.
‡t-test for signiﬁcance between sexes; when using the Mann–Whitney U-test, the same differences were signiﬁcant, in addition annual costs for medical supply and dentures were
signiﬁcantly different (P = 0.022).
§c2-test.
¶Fisher’s exact test.
n.s., not signiﬁcant.
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Only one respondent used a specialized hospital for
psychiatric and neurological care. 5.1% had been
admitted to rehabilitation hospitals with an average
length of stay of 19.9 days and a maximum of one stay
per user. 34.8% of admissions to hospitals for reha-
bilitation followed surgery in general hospitals. Inpa-
tient care was the main cost category, accounting for
34% of total annual direct costs. The mean cost per
year of respondents, admitted for inpatient care at
least once was €7304. Annual mean costs of all respon-
dents were €1260. Costs ranged from €0 to €22,392
with no signiﬁcant difference in mean costs between
women and men.
Pharmaceuticals. Pharmaceuticals were used by most
(98.0%) of the participants during the preceding
3 months. Signiﬁcantly more women (4.6%) used at
least one pharmaceutical. On average about ﬁve phar-
maceuticals were used, with a maximum of 19. The
most frequently indicated medical categories for calcu-
lating the CDS were pharmaceuticals for heart diseases
(44%), hypertension (30%), and diabetes mellitus
(6%). Pharmaceuticals made up the second most
important cost component, accounting for 29% of
total annual direct costs. The annual mean pharma-
ceutical cost per respondent was €1075. Costs ranged
from €0 to €26,421, with no signiﬁcant difference in
mean costs between women and men.
Outpatient physician service. Ninety-eight percent of
the respondents had used at least one outpatient phy-
sician service during the preceding 3 months. Outpa-
tient physician services were divided into four main
categories: visits to GPs, specialists, to outpatient
clinics, and whether surgeries in an outpatient setting
were performed or not. Table 4 shows service utiliza-
tion and costs by main physician services. Specialists
not listed in Table 4 (e.g., psychiatrists) were used by
less than 10% of respondents per sex and are therefore
not shown. The main outpatient physician service used
by the advanced elderly was the GP, accounting for
20.3% of total outpatient physician service costs. The
main utilized specialist was the ophthalmologist,
accounting for 8.3% of total outpatient physician
service costs. Second in utilization for women was the
orthopedist and for men the urologist. Men used the
cardiologist and the urologist signiﬁcantly more often,
while women the gynecologist. Once the physician was
contacted, no signiﬁcant differences in number, dura-
tion of contacts, or costs could be found between
sexes. Yet, considering mean costs per respondent and
not per user, women had signiﬁcantly higher mean
costs for the gynecologist and men for the urologist.
The use of an outpatient clinic or operations in an
outpatient setting did not play an important role, with
the latter being used by only 2.2% of the respondents.
In total, outpatient physician services accounted for Ta
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15% of total annual direct costs with annual mean
costs per respondent of €546. Outpatient costs ranged
from €0 to €40,311 per year with no signiﬁcant differ-
ence in mean costs between sexes. The high upper limit
was caused by a respondent receiving dialysis, provid-
ing the greater contribution to the absolute yet not
signiﬁcant difference in mean outpatient costs of €284
between women and men. Without this outlier, mean
costs for men would amount to €484.
Other services and goods. All other services except
transportation were used by less than 30%. Nursing
care was used by 22.8% of the respondents during
the preceding 12 months. These included beneﬁts and
services from compulsory long-term care insurances
as well as privately paid expenses for nurses, house-
hold services, and meal delivery. Of those respon-
dents who received any nursing care, 26.2% received
beneﬁts or services from the long-term care insur-
ance, the latter accounting for 72.5% of the total
nursing care costs. A total of 77.8% of respondents
who received beneﬁts or services from the long-term
care insurance were classiﬁed stage I according to the
classiﬁcation system of the long-term care insurance
[36]; 22.2% were classiﬁed as stage II. Costs for
nursing care accounted for 10% of total annual
direct costs. Costs ranged from €0 to €14,053 per
year. Assisted living was used by 4.4% of the respon-
dents during the preceding 6 months. Yearly costs for
assisted living accounted for 1% of total annual
direct costs, ranging from €0 to €1534 per year.
Medical supply and dentures were used by 15.7% of
respondents during the preceding 3 months. Yearly
costs accounted for 6% of total annual direct costs,
ranging from €0 to €8485 per year. Outpatient non-
physician providers were used by 29.0% of the
respondents during the preceding 3 months. The
respondents used the following services most often:
massage or lymph drainage 15.3%, physiotherapy
10.8%, and electrotherapy or light therapy 4.2%.
Yearly costs for outpatient nonphysician providers
accounted for 5% of total annual direct costs,
ranging from €0 to €3195 per year. Women used all
these other services and goods signiﬁcantly more
often with signiﬁcantly higher mean costs, except for
medical supply and dentures.
Transportation by car, public transport, taxi, or
ambulance to medical visits or treatments was used by
about half (53.8%) of the participants during the pre-
ceding 3 months. The main mode of transportation
was the tram used by 31.9%. Transportation costs
accounted for 2% of the total direct costs. Annual
transportation costs ranged from €0 to €2275.
Excess Service Utilization and Health-Care Costs
Associated with Speciﬁc Diseases
Ischemic heart disease. Forty-four percent (n = 191)
of the respondents suffered from ischemic heart disease
with relatively more men (52%) than women (39%)
being affected. Table 5 shows the prevalence-based
excess service utilization in percent and the mean
annual excess costs of respondents associated with
ischemic heart disease. There was no signiﬁcant excess
service utilization when both sexes were considered
together. Differentiated by sex, signiﬁcant excess
service utilization of those with ischemic heart diseases
was most pronounced in transportation for men, with
18.9% more men using at least one mode of transpor-
tation. Inpatient care, pharmaceuticals, outpatient
physician services, and nursing care were also used
signiﬁcantly more frequently by men with this
diagnosis.
Considering all respondents excess costs were €711,
yet not signiﬁcant. Signiﬁcant excess cost components
were found only for nursing care. Sex-speciﬁc, signiﬁ-
cant excess costs were found in nursing care for
Table 5 Excess service utilization and excess costs of respondents associated with ischemic heart disease or diabetes mellitus
Sector
Excess service utilization in %* (excess annual costs in €)†
Ischemic heart disease Diabetes mellitus
All
n = 434‡
Female
n = 273
Male
n = 161
All
n = 445‡
Female
n = 281
Male
n = 164
Inpatient care 5.2 (437) -1.3 (-186) 14.4 (1443) 1.4 (1) -5.7 (-232) 12.8 (385)
Pharmaceuticals 2.8 (21)§ 0.6 (-96)§ 7.9 (211)§ 1.7 (407)§ 0.5 (577)§ 3.9 (125)
Outpatient physician service 2.4 (-160) 0.3 (-53) 6.5 (-438)§ 2.8 (-118) 1.5 (-48) 5.2 (-247)
Nursing care 5.2 (306) 2.5 (505) 13.5 (94)§ -0.7 (-9) 2.1 (83) -4.7 (-149)
Assisted living 0.6 (-2) -0.4 (-7) 3.6 (19) -1.5 (-9) -2.6 (-22) 0.4 (16)
Medical supply and dentures -3.3 (70) -5.5 (-67) 2.8 (295) 1.7 (27) 2.8 (13) 0.1 (49)
Outpatient nonphysician provider 0 (31) 2.3 (62) -0.8 (16) -4.7 (6) -2.2 (48) -8.3 (-58)
Transportation 8.8 (7) 2.7 (-24) 18.9 (51)§ 2.9 (-15) 0.6 (-33) 6.6 (13)
Any service/good 1.2 (711)§ 0 (134) 3.9 (1690)§ 0.9 (290) 0 (386) 2.6 (134)
*During the preceding 3 months except for inpatient care, assisted living (6 months), and nursing care (12 months).
†Signiﬁcant differences from zero of excess service utilization and excess costs are printed in bold (c2-test and Fisher’s exact test for differences in proportions, t-test for
differences in means).
‡Difference from n = 452, is due to missing values for the diagnosis.
§Signiﬁcant when applying the Mann–Whitney U-test.
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women and inpatient care for men. Inpatient care for
men accounted for 85% of the total excess costs.
Diabetes mellitus. Twenty-eight percent (n = 126) of
the respondents had a diagnosis of diabetes mellitus
(male 29%, female 28%). Total annual excess costs for
both sexes were €290, yet not signiﬁcant (Table 5).
Only costs for transportation for women with diabetes
were signiﬁcantly lower than for women without dia-
betes mellitus.
Multivariate Analysis
For assessing the inﬂuence of various independent vari-
ables on total annual direct costs in EUR, multivariate
ordinary least square (OLS) regression models with
nonparametric bootstrapped standard errors (3000
replications) and bias-corrected conﬁdence intervals
were applied (Table 6). At ﬁrst a pure socio-
demographic model without any variable for health
status was analyzed (Model 1). In all, 1.3% of the
variation of total direct costs could be explained by
age, sex, education, family status, with no independent
variable being signiﬁcant. Adding the two highly
prevalent diseases examined (Model 2) resulted in an
explained variance of 1.9% with no variable being
signiﬁcant. By replacing the two diseases with the CDS
score as a general measure of morbidity (Model 3), the
explained variance rose to 6.3%. In this model, total
direct costs rose signiﬁcantly with a larger CDS score
and a shift from lower to middle education. A one-
point increase in CDS was associated with an increase
of €482 (95% CI 316–654); a change in education
level from low to middle increased mean direct costs
by €1678 (95% CI 250–3369).
Sensitivity Analysis
Health-care costs are dependent on the monetary value
put on the different services and goods utilized. To test
the possible effects of uncertainty with regard to unit
costs, we applied alternative approaches for the main
cost components in a sensitivity analysis. Replacing the
per diem rate for inpatient care in general hospitals
with the value of the DRG, based on information
provided by the patient and assuming the lowest mor-
bidity and complexity level, total inpatient costs were
reduced by 4.1% and total mean costs by 1.4%. Out-
patient physician services were alternatively valued
with type-speciﬁc budgets for the advanced elderly,
leading to an increase of 2.5% of mean total costs. The
increase in using the budget approach compared to the
base-case analysis is due to the relatively small number
of contacts and short duration of time for outpatient
physician services of many patients.
Discussion
People aged more than 75 years used a wide range of
health-care services and goods. Almost every respon-
dent used at least one health-care service/good during
the preceding months considered. Ninety-eight percent
used pharmaceuticals and outpatient physician ser-
vices. The main cost components accounting for 78%
of total direct costs were inpatient care, pharmaceuti-
cals, and outpatient physician services. Adjustment for
sex to the original sample ratio resulted in €2 higher
total mean costs. Total mean excess costs for respon-
dents who had ischemic heart disease were €711 and
for diabetes mellitus €290, both being not signiﬁcant.
Signiﬁcant predictors for higher total mean costs in
EUR were the CDS and a shift from lower to middle
education. Despite signiﬁcant differences in service uti-
lization between women and men, mean total direct
costs did not differ signiﬁcantly. Altogether, 55% of
the respondents caused 90% of the total direct costs.
Although our sampling approach can be considered
to derive an almost representative population sample,
since 93% of people aged 70+ are regularly seen by a
GP [43], the representativeness and generalizability of
Table 6 Results of three multiple linear regression models using annual direct costs (in €) as dependent variable*
Model 1 (n = 452) Model 2 (n = 434) Model 3‡ (n = 452)
Coefﬁcient (95% CI†) P-value Coefﬁcient (95% CI†) P-value Coefﬁcient (95% CI†) P-value
Constant 3676.41 (2670.39–4749.86) 0.000 3309.75 (2123.76–4592.11) 0.000 1496.16 (350.14–2698.52) 0.013
Age (year) -37.19 (-163.01–73.81) 0.539 -41.70 (-170.84–75.39) 0.505 -61.18 (-180.77–59.76) 0.320
Sex (male = 1) -116.57 (-1036.28–830.21) 0.806 -272.35 (-1233.22–706.07) 0.582 -470.55 (-1348.73–391.68) 0.296
Family status -435.22 (-1483.13–640.35) 0.417 -390.51 (-1540.87–621.95) 0.473 -306.49 (-1336.71–726.26) 0.553
Educational level
(reference low)
Middle 1467.25 (71.12–3143.73) 0.063 1611.95 (109.24–3415.75) 0.052 1678.07 (249.84–3369.08) 0.037
High 1220.78 (-192.85–3273.66) 0.163 1333.33 (-4.33–3444.87) 0.118 1405.70 (6.72–3474.26) 0.102
Ischemic heart disease — 705.45 (-411.86–1736.47) 0.197 —
Diabetes mellitus — 439.46 (-668.48–1576.41) 0.445 —
CDS — — 481.91 (315.81–653.66) 0.000
R2 (adjusted) 0.013 (0.002) 0.019 (0.003) 0.063 (0.050)
*Non-parametric bootstrapped standard errors (3000 replications).
†Bias-corrected conﬁdence intervals.
‡To avoid collinearity, analyzed diseases were excluded from the independent variables, because the CDS contains heart disease and diabetes mellitus.
CDS, chronic disease score; CI, conﬁdence interval.
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our ﬁndings is restricted. Compared to the general
population in this age group, our respondents were
slightly younger, consisted of more men and fewer
were widowed [44]. Additionally, sociodemographic
variables, health characteristics, and unit costs reﬂect
patterns in the region of East Germany (former GDR),
making a generalizability for Germany as a whole
difﬁcult [45,46].
Furthermore, our service utilization frequencies and
mean costs of care are likely to underestimate the true
frequencies and costs incurred by society in the region,
mainly because our primary care sample did not
include institutionalized patients and patients with
severe illness proving fatal within 3 months. This indi-
cates also a rather low proportion of people in a close
proximity to death. On the other hand, our sample did
not include individuals who had not seen the GP
within the last 12 months at the time of recruiting,
missing those utilizing the system less frequently. This
bias within the observed period persists when costs are
extrapolated to annual costs. Second, we did not con-
sider several cost components incurred by society, for
example, informal care and indirect costs, caused by
paid or unpaid work loss, like forgone caring time for
grandchildren. We also did not include additional costs
for family members while accompanying the advanced
elderly to medical appointments. Third, we asked for
doses and durations for pharmaceuticals used within
the preceding 3 months and assumed that this amount
was collected in the cheapest combination of packages,
thus missing any pharmaceuticals purchased but not
taken by the respondents.
A comparison of our results is restricted by the lack
of publications for this special age group in Germany
and internationally and the different age spans in
studies considered. To the authors’ knowledge, no
service utilization and bottom-up costing study of
people aged 75+ from a societal perspective has been
published so far. Nevertheless, ﬁrst, a view can be
established on some aspect of service utilization. Our
service utilization rate of general hospitals is below
that of the Berlin Aging study [43] and a study by
Winter et al. [47] providing an annual rate of about
20%. This is most likely due to our recruitment
scheme, our 6-month retrospective time span and dif-
ferent spans of ages considered. Once admitted to
general hospitals, we could reveal almost the same
length of stay compared to ﬁgures reported by Schulte
[48], which state an average length of stay in general
hospitals for people aged 75+ of 11.3 days. Concern-
ing pharmaceuticals, we have a slightly higher utiliza-
tion rate than discovered in a sample of people being
60+ [13]. Yet the mean number of pharmaceuticals
used corresponds to about four assessed in a study
sample with a mean age of 71.5 years [49]. At last
96.9% of our respondents contacted the GP in the
preceding 3 months at least once, which reﬂects the
ﬁnding of the Berlin Aging study [43]. Second, com-
paring our costs to other sources seems to underpin
our already stated underestimation of costs. The risk
compensation scheme between German sickness funds
paid €4178 per person for the age of 75+ in 2004 [50].
The Federal Statistic Ofﬁce in Germany states mean
health-care cost per inhabitant of €5950 in 2004 for
the age range of 65 to 85 years [51]. In addition to
the points already mentioned, a further reason for this
difference in cost-level can be found in the bottom-up
approach we chose in comparison to the top-down
approach applied by the Federal Statistic Ofﬁce.
Future demographic change will bring the age
group of the advanced elderly to the focus of health
policymakers. The present ﬁgures can help with plan-
ning and modeling purposes for key players and scien-
tists on every level of the health-care system. Main cost
components and costly diseases show where efforts
concerning prevention and management programs of
the different players in the health-care system should
be focused. Yet concentrating on service utilization and
direct costs of the advanced elderly can only be the
starting point for further health economic analyses,
because it does not consider health outcomes resulting
from the used health-care services/goods. Therefore, to
improve efﬁciency in health-care systems, efforts
should focus on economic evaluation of new health-
care programs for heavy users, thereby concentrating
on the three main cost categories.
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